Optimisation of the Manufacturing Process of Organic-Solvent-Free Omeprazole Enteric Pellets for the Paediatric Population: Full Factorial Design
-
Published:2023-11-04
Issue:11
Volume:15
Page:2587
-
ISSN:1999-4923
-
Container-title:Pharmaceutics
-
language:en
-
Short-container-title:Pharmaceutics
Author:
Rouaz-El-Hajoui Khadija1ORCID, García-Montoya Encarnación12ORCID, López-Urbano Andrea1, Romero-Obon Miquel3, Chiclana-Rodríguez Blanca1ORCID, Fraschi-Nieto Alex1, Nardi-Ricart Anna1ORCID, Suñé-Pou Marc12ORCID, Suñé-Negre Josep María12, Pérez-Lozano Pilar12ORCID
Affiliation:
1. Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Av. Joan XXIII, 27-31, 08028 Barcelona, Spain 2. Pharmacotherapy, Pharmacogenetics and Pharmaceutical Technology Research Group, Bellvitge Biomedical Research Institute (IDIBELL), Av. Gran Via de l’Hospitalet, 199-203, 08090 Barcelona, Spain 3. Laboratorios ALMIRALL, Ctra. de Martorell, 41-61, 08740 Sant Andreu de la Barca, Spain
Abstract
Liquid formulations are mostly used in the paediatric population. However, with certain active pharmaceutical ingredients (APIs), it is very difficult to guarantee quality and stability; this is the case, for example, with omeprazole. Omeprazole is used as a model drug due to the lack of a paediatric formulation meeting gastro-resistance requirements, which remains a challenge today. In this experimental study, the development of enteric polymer-coated pellets is proposed. It is proposed to use aqueous coating dispersions without the use of organic solvents, which are commonly used in fluidised bed coatings. To do this, the design of experiments method is used as a statistical tool for experiment creation and the subsequent analysis of the responses. In particular, this study uses a randomised full factorial design. The mean weight increases of the protective layer and the enteric coating are chosen as factors. Each factor is assigned two levels. Therefore, the design of the used experiments is a 22 + 1 central point. Overall, the obtained pellets can be an alternative to the compounding formulas of omeprazole that are currently used in the paediatric population, which do not meet the gastro-resistance specifications necessary to guarantee the therapeutic efficacy of this active ingredient.
Funder
Departament de Recerca i Universitats de la Generalitat de Catalunya
Subject
Pharmaceutical Science
Reference30 articles.
1. Formulación Magistral y Excipientes En Pediatría Correspondencia;Farmacéutico. Hosp.,2018 2. Rouaz, K., Chiclana-Rodríguez, B., Nardi-Ricart, A., Suñé-Pou, M., Mercadé-Frutos, D., Suñé-Negre, J.M., Pérez-Lozano, P., and García-Montoya, E. (2021). Excipients in the Paediatric Population: A Review. Pharmaceutics, 13. 3. Medication Use in Children: A Survey among Hospital Pediatricians in Morocco;Yafout;Pharm. Clin.,2022 4. Pediatric Prescriptions of Proton Pump Inhibitors in France (2009–2019): A Time-Series Analysis of Trends and Practice Guidelines Impact;Yang;J. Pediatr.,2022 5. Tiengkate, P., Lallemant, M., Charoenkwan, P., Angkurawaranon, C., Kanjanarat, P., Suwannaprom, P., and Borriharn, P. (2022). Gaps in Accessibility of Pediatric Formulations: A Cross-Sectional Observational Study of a Teaching Hospital in Northern Thailand. Children, 9.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|